Literature DB >> 11757628

The impact of meconium ileus on the clinical course of children with cystic fibrosis.

A K Evans1, D A Fitzgerald, K O McKay.   

Abstract

The present study was designed to compare the clinical course of children diagnosed with cystic fibrosis (CF) in infancy due to the presence of meconium ileus (MI) with children diagnosed by way of a newborn screening programme (non-MI). A matched case-control study design was used. Matching was performed on the basis of sex and date of birth. All children born in New South Wales, Australia after 1980 and who had attended the CF clinic at The Children's Hospital at Westmead since diagnosis were included as possible cases or controls. Parameters pertaining to the clinical course were compared in 39 matched pairs. MI children had a significantly worse pulmonary status. The forced expiratory volume in one second was 16.3 +/- 5.2% higher (p<0.001, n=21 pairs) and the forced vital capacity value 10.5 +/- 4.7%, higher (p<0.05, n=21 pairs) in non-MI children. The difference between the pairs (18.6 +/- 4.4 MI and 20.5 +/- 3.4 non-MI) in the Shwachman chest radiograph score was statistically significant (p<0.05, n=39 pairs). There were no significant differences in any other assessed parameters, such as height, weight, the presence of liver function abnormalities, the frequency of hospitalization or airway microbial colonization. Meconium ileus may be an early indication of a more severe phenotype of cystic fibrosis. This was suggested by the significantly lower pulmonary function found in children with a history of meconium ileus compared to age- and sex-matched children who did not have meconium ileus.

Entities:  

Mesh:

Year:  2001        PMID: 11757628     DOI: 10.1183/09031936.01.00053701

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Immunoreactive trypsin levels in neonates with meconium ileus.

Authors:  L C Steven; G Gavel; D Young; R Carachi
Journal:  Pediatr Surg Int       Date:  2006-01-03       Impact factor: 1.827

2.  Body composition and lung function in children with cystic fibrosis and meconium ileus.

Authors:  Artemis Doulgeraki; Argyri Petrocheilou; Glykeria Petrocheilou; George Chrousos; Stavros-Eleftherios Doudounakis; Athanasios G Kaditis
Journal:  Eur J Pediatr       Date:  2017-04-13       Impact factor: 3.183

3.  Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

Authors:  Scott M Blackman; Rebecca Deering-Brose; Rita McWilliams; Kathleen Naughton; Barbara Coleman; Teresa Lai; Marilyn Algire; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; M Daniele Fallin; Kristen West; Dan E Arking; Aravinda Chakravarti; David J Cutler; Garry R Cutting
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

4.  Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  Moran Lavie; Tzipora Manovitz; Daphna Vilozni; Sarina Levy-Mendelovich; Ifat Sarouk; Ilana Weintraubv; David Shoseyov; Malena Cohen-Cymberknoh; Joseph Rivlin; Ori Efrati
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 5.  Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.

Authors:  Hubert P J van der Doef; Freddy T M Kokke; Cornelis K van der Ent; Roderick H J Houwen
Journal:  Curr Gastroenterol Rep       Date:  2011-06

6.  Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

Authors:  Lindsay B Henderson; Vishal K Doshi; Scott M Blackman; Kathleen M Naughton; Rhonda G Pace; Jackob Moskovitz; Michael R Knowles; Peter R Durie; Mitchell L Drumm; Garry R Cutting
Journal:  PLoS Genet       Date:  2012-03-15       Impact factor: 5.917

7.  Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts.

Authors:  Kathryn A Ramsey; Emily Hart; Lidija Turkovic; Marc Padros-Goossens; Stephen M Stick; Sarath C Ranganathan
Journal:  ERJ Open Res       Date:  2016-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.